Qure.ai — which is headquartered in India — closed a $65 million Series D financing round. When asked whether the startup is ...

Centivo's $75 million raise includes funding from new investors Cone Health Ventures and MemorialCare Innovation Fund, as ...

Johnson & Johnson stopped short of implementing its proposal to alter the way two drugs are paid for under the 340B drug discount program, but the drugmaker made it clear it still wants changes. In ...

Shortly after releasing a scathing interim report in July that revealed how three players dominate the pharmacy benefit manager market and raise drug costs for patients, the Federal Trade ...

Arundhati Parmar is VP and Editor-in-Chief at MedCity News. In this role, she oversees MedCity's news coverage as well as develops the content for several conferences that the publication hosts.

The 2024 election is nearing the corner and has major implications for the healthcare industry, from abortion to drug pricing. During the Reuters Total Health Conference held in Chicago on Tuesday ...

Health systems have spent billions on portals while investments in modernizing the voice channel — the dominant preference of healthcare consumers — have taken a backseat.

Recent moves by the Food and Drug Administration have given digital health companies a big boost during the Covid-19 pandemic. The FDA gave Livongo an emergency use authorization to allow its ...

Maven Clinic, a virtual clinic for women’s and family health, has secured $125 million in Series F funding, the company announced Tuesday. New York City-based Maven Clinic offers support for ...

With pressure building on Congress to solidify telehealth payment flexibilities set to expire at the end of the year, we must ensure legislators weigh the ability of virtual health care services ...

Hospitals have never had a warm and fuzzy relationship with insurers — and it doesn’t seem like their bond will be getting stronger any time soon, according to a recent report from the ...

Scholar Rock contends its experimental drug for spinal muscular atrophy can achieve what none of the currently available therapies can do to treat this rare disease. After positive data from a ...